Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

UCB reports positive results from phase III trial of Vimpat for diabetic neuropathic pain

Dec. 14, 2007

TorreyPines Therapeutics reports positive results from phase I clinical trial of NGX-426

Dec. 14, 2007

Plasmid-mediated delivery of IGF-1 gene useful in mouse model of ALS

Dec. 14, 2007

Targacept initiates phase I clinical trial of TC-6499 for neuropathic pain

Dec. 13, 2007

AVANIR initiates enrollment in phase III trial of Zenvia for pseudobulbar affect

Dec. 13, 2007

Mutant MOR gene transfer plus naloxone treatment leads to analgesia without tolerance in mice

Dec. 13, 2007

New therapeutic agents for neurological disorders reported in recent patents

Dec. 13, 2007

FDA issues approvable letter for GSK's Requip XL for idiopathic Parkinson's disease

Dec. 12, 2007

Neurotrophic-expressing AAV vectors improve symptoms in mouse model of ALS

Dec. 12, 2007

Lexicon initiates phase IIa trial of LX-6171 for cognitive disorders

Dec. 12, 2007

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...